ABSTRACT: 3,3=-diiodothyronine sulfate (T 2 S) derived from T 3 of fetal origin is transferred to the maternal circulation and contributes significantly to the maternal urinary pool. The present study quantitatively assesses the fetal to maternal transfer of T 4 metabolites compared with those of T 3 . Labeled T 4 or T 3 was infused intravenously to four singleton fetuses in utero in each group at gestational age 138 Ϯ 3 d. Maternal and fetal serum and maternal urine samples were collected hourly for 4 h and at 24 h (serum) or in pooled 4 -24 h samples (urine). Radioactive metabolites were identified by HPLC and by specific antibody in serum and urine extracts and expressed as percentage infusion dose per liter. The results demonstrate a rapid clearance of labeled T 3 from fetal serum (disappearance T 1/2 of 0.7 h versus 2.4 h for T 4 in the first 4 h). The metabolites found in fetal serum after labeled T 3 infusion were T 2 S Ͼ T 3 Ͼ T 3 S; in maternal urine, T 2 S Ͼ unconjugated iodothyronines (UI) Ͼ T 3 S Ͼ unknown metabolite (UM). After labeled T 4 infusion, the metabolites in fetal serum were rT 3 Ͼ T 3 Ͼ T 2 S Ͼ T 4 S in the first 4 h, and rT 3 ϭ T 3 ϭ T 4 S ϭ T 2 S Ͼ T 3 S at 24 h; in maternal urine we found T 2 S Ͼ UM Ͼ UI Ͼ T 4 S Ͼ T 3 S in the first 4 h and UM Ͼ T 2 S Ͼ UI in 4 -24 h pooled sample. In conclusion, the conversion of T 3 to T 2 S followed by fetal to maternal transfer of T 2 S and other iodothyronines appears to contribute importantly to maintaining low fetal T 3 levels in late gestation. (Pediatr Res 59: 102-106, 2006) K inetic studies in fetal sheep in late gestation (Ͼ135 d of gestational age; term, 150 d) showed that mean fetal T 4 CR and PR are significantly higher than the corresponding values in adult sheep (1). The ratio of mean PR of rT 3 to T 4 is similar in fetal and adult sheep, whereas the PR ratio of T 3 to T 4 in fetal sheep is much lower than that in adult sheep. These data in the ovine fetus indicate that the prevailing low serum T 3 concentration is due both to increased CR and decreased PR, whereas the elevated serum rT 3 levels are due to decreased CR and increased PR. We and others showed that sulfated iodothyronines, including T 4 S, T 3 S, rT 3 S, and 3,3=-T 2 S are major T 4 metabolites in ovine fetuses (2,3). The PR of T 4 S, T 3 S, rT 3 S, and rT 3 significantly exceed the PR of T 3 .
K inetic studies in fetal sheep in late gestation (Ͼ135 d of gestational age; term, 150 d) showed that mean fetal T 4 CR and PR are significantly higher than the corresponding values in adult sheep (1) . The ratio of mean PR of rT 3 to T 4 is similar in fetal and adult sheep, whereas the PR ratio of T 3 to T 4 in fetal sheep is much lower than that in adult sheep. These data in the ovine fetus indicate that the prevailing low serum T 3 concentration is due both to increased CR and decreased PR, whereas the elevated serum rT 3 levels are due to decreased CR and increased PR. We and others showed that sulfated iodothyronines, including T 4 S, T 3 S, rT 3 S, and 3,3=-T 2 S are major T 4 metabolites in ovine fetuses (2, 3) . The PR of T 4 S, T 3 S, rT 3 S, and rT 3 significantly exceed the PR of T 3 .
Thus, peripheral thyroid hormone metabolism in the ovine fetus, in contrast to the adult, is shunted to inactivation rather than production of active hormone.
In a recent study, we showed that a significant amount of 3,3=-diiodothyronine (T 2 ), the inner-ring deiodinated metabolite of fetal T 3 , is found in maternal urine as sulfated T 2 when 125 I-T 3 is infused in venously catheterized fetuses (4, 5) . In contrast, when a supraphysiological dose of T 3 , about 200-fold the fetal T 3 PR, was infused into fetuses, both T 2 S and T 3 S were found in maternal urine (6) . To exclude the possibility that the observed fetal-to-maternal transfer of metabolites could be a pharmacological dose effect, the present study was conducted to quantify the radioactivities and identify the metabolites in fetal serum and maternal serum and urine following fetal infusion of 125 I-T 4 contrasted with results after infusion of 125 I-T 3 .
MATERIALS AND METHODS
Animal preparation. Western mixed-breed, time-dated pregnant ewes with singleton pregnancies were obtained from the Nebeker Ranch (Lancaster, CA) and acclimated to laboratory conditions and food. Animals were studied in two groups, four in each group.
The ewes (131 Ϯ 2 d) were sedated (1.2 mg atropine and 700 mg ketamine i.m.), and a continuous infusion of ketamine (100 mg/h) begun via a jugular venous catheter. After local anesthesia of the abdominal wall (2% lidocaine), a midline incision was followed by palpation of the uterus and fetal parts and identification of the fetal abdomen. A hysterotomy was performed over the fetal lower abdomen and fetal membranes were marsupialized to the skin of the fetal abdomen, avoiding loss of amniotic fluid. The groin area of the singleton fetus was infiltrated with 1% lidocaine, followed by the incision and insertion of catheters in both the femoral vein and artery. The incisions were closed. In each group, the ewes were treated for 3 d postoperatively with oxacillin (2 g) and gentamicin (80 mg) daily given intramuscularly in divided doses. The fetal arterial blood gas and pH were monitored at the beginning and at the end of the infusion study to ascertain normalcy of arterial PO 2 and pH values.
Seven to 10 d later, outer-ring labeled 125 I-T 3 (250 Ci, sp. act. 1300 Ci/g) or 125 I-T 4 (250 Ci, sp. act. 5700 Ci/g) diluted in saline was given in a single bolus via the fetal femoral venous catheter. Maternal and fetal serum samples were collected hourly for 4 h and at 24 h. Maternal urinary samples were collected hourly for the first 4 h and then were pooled from 4 to 24 h. All experiments were approved by the Harbor-UCLA Medical Center Animal Use Committee.
In a separate experiment, involving three pregnant sheep with singleton fetuses, the fetuses and ewes were similarly treated.
125 I-T 4 was infused into the maternal femoral vein; serum and urine samples were similarly collected from both mother and fetus.
Identification of labeled metabolites in fetal serum and maternal sheep urine and serum. After fetuses were infused with 125 I-T 3 or 125 I-T 4 , radioactive metabolites were identified in fetal serum in hourly samples (in one and four lambs after 125 I-T 3 and 125 I-T 4 infusion, respectively) and maternal urine extracts (hourly samples from all four sheep of each group). Urine and serum samples were extracted with two volumes of 95% ethanol and subsequently lyophilized. The dried extracts were dissolved in 1 mL of H 2 O and purified using an LH-20 column as previously described (6) . After application to an HPLC -Bondapak C 18 column (Waters, Milford, MA), the extracts were eluted isocratically with a mixture of acetonitrile and 0.02M ammonium acetate, pH 4.0 (22:78 vol/vol) at a flow rate of 2 mL/min. Aliquots of eluent in 1-mL fractions were collected and 100 L of these aliquots with significant radioactivities (found only in maternal urine samples following 125 I-T 3 infusion) were subjected to immunoprecipitation with specific antibodies to T 2 S, as a major peak. Minor peaks were identified by comparing their retention times to those of known synthetic iodothyronines eluted on HPLC under the same conditions. Hourly urine samples (n ϭ 7) of the identified T 2 S peaks from two 125 I-T 3 infusion studies in duplicate were subjected to polyclonal rabbit T 2 S antibody precipitation; T 2 S-specific activities were varied from 93.6% to 99.9% (mean 97.6%). Radioactivities in urine or serum extracts were expressed as percentage of injected total dose. Duplicate 0.1% aliquots of the total infused dose were used in each infusion study as counting standards.
T 2 S RIA. T 2 S levels in serum and urine were measured by specific and sensitive RIA methods as described previously (5). Serum and urine samples were extracted with two volumes of 95% ethanol (final ethanol concentration 63%). T 2 S RIA has a lower limit of detection of 2 ng/dL (33 pmol/L). Among various thyroid hormone analogs studied and known to exist in sheep serum or urine, only T 3 S, rT 3 S, and T 4 S cross-react significantly (3.2, 1.4, and 0.02%, respectively) in the T 2 S RIA; T 4 , T 3 , rT 3 , and T 2 cross-reacted Ͻ0.0001%. The T 2 S concentrations in serum and urine were not corrected for the cross-reactivity of T 3 S.
Source of materials. 3,3=-T 2, T 3 , and T 4 were purchased from HenningBerlin Co. (Berlin, Germany).
125 I-3,3=-T 2 was prepared by radioiodination using the method described previously (7) . T 3 S and T 2 S were synthesized as described by Mol and Visser et al. (8, 9) . Chlorosulfonic acid, 99%, was purchased from Aldrich Chemical Co. (Milwaukee, WI). Outer-ring labeled 125 I-T 4 and 125 I-T 3 were purchased from PerkinElmer NEN (Boston, MA). Figure 1 shows radioactivities expressed as percentage of infused dose of radioactive T 3 or T 4 per liter of serum (% dose/L) in fetuses following the bolus infusion of 125 I-T 3 or 125 I-T 4 , respectively. There was a rapid decrease in serum 125 I-T 3 , which dropped about 75% in the first hour and 96% by the end of 4 h, then transited to a slow phase from 4 to 24 hour. Similarly, serum 125 I-T 4 showed a rapid clearance phase during the first 2 h followed by a slow phase. Fetal serum samples analyzed by HPLC at each time period from one fetal sheep showed that T 3 decreased rapidly after 125 I-T 3 infusion; levels dropped to 4.3% dose/L at the end of h 4 from 94.2% dose/L at the end of h 1, with a disappearance T 1/2 of approximately 0.7 h. T 2 S, the major metabolite, on the other hand, increased to 15.4% dose/L from 7.2% dose/L over the same period of time (Table 1) . By contrast, there was a slower decrease in T 4 following 125 I-T 4 infusion, from 215% dose/L in the first hour to 125% dose/L at the end of 4 h. RT 3 and T 3 were the major metabolites after 125 I-T 4 infusion; respective levels increased from 1.8 and 2.2% dose/L at 1 h to 2.6% and 2.9% dose/L at the end of 24 h. T 2 S and T 4 S, the less abundant metabolites, rose from 0.3 and 0.5% dose/L to 1.9 and 2.3% dose/L at 24 h. Negligible amount of rT 3 S were observed after 125 I-T 4 infusion. Metabolites found in maternal serum and urine after fetuses received 125 I-T 3 or -T 4 intravenously. A total of 15.9% radioactivity was recovered in maternal urine in the first 4 h following fetal infusion of 125 I-T 3 whereas only 1.0% was recovered following 125 I-T 4 infusion ( Table 2 ). In contrast, little radioactivity was found in maternal serum after fetal infusion of 125 I-T 3 , an average of 2.2% of the infused dose/L during the first 4 h and 1.0% dose/L at 24 h (Table 3) . Even less radioactivity was found in maternal sera after fetal infusion of 125 I-T 4 , 0.22% dose/L at the first hour increasing to 1.4% dose/L at the end of 24 h ( Table 3) . Because of the low levels of radioactivity, the metabolites were not characterized by HPLC following 125 I-T 4 infusion. In one maternal serum sample characterized by HPLC 2 h after 125 I-T 3 infusion, the major metabolites were free iodide and T 2 S (44.6 and 43.7% of radioactivity distribution, respectively). Minor peaks included T 2 and T 3 (3.9 and 4.1%, respectively).
RESULTS

Characterization of fetal serum metabolites after fetal infusion of labeled T 3 or T 4 .
The major metabolites found in maternal urine were similar after fetal infusion of either 125 I-T 3 or 125 I-T 4 , but significantly higher amounts were recovered after T 3 infusion than after T 4 infusion. Following 125 I-T 3 infusion, 46.4% of radioactivity was found in the T 2 S peak in the 1-h maternal urine; the identity of T 2 S was confirmed by precipitation with a T 2 Sspecific antibody. The percentage of T 2 S gradually decreased to 22.8% in h 4 and to 6.1% in the 4 -24 h pooled urine sample. The iodide fraction increased from 42.4% in the h 1 urine sample to 84.9% in the 4 -24 h pooled urine. Expressed 
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as percentage dose, 43.7% of the 125 I-T 3 radioactivity was recovered in maternal urine in 24 h and 6.4% dose was recovered as T 2 S. After fetal infusion of 125 I-T 4 , 6.1% of the radioactivity in maternal urine was identified as T 2 S, whereas 89.4% was iodide at 1 h, and at 4 h, 5.6% of urinary radioactivity is still present in the T 2 S peak. A peak of an unknown compound appeared after infusion of labeled T 3 or T 4 , amounting to about 8% in the 4 -24 h samples in each case (Table 2) .
Specific activity of T 2 S in fetal sera and maternal urine after fetal infusion of 125 I-T 3 or 125 I-T 4 . T 2 S levels were measured in selected fetal serum and maternal urine samples and their specific activities were calculated and expressed as percentage dose per microgram T 2 S (Table 4) . Significantly higher specific activities were found in fetal serum compared with maternal urine after either labeled T 3 or T 4 infusion in the fetuses. After T 3 infusion, however, T 2 S specific activity in both serum and urine reached a peak early, around h 2, whereas the specific T 2 S activity continued to increase up to 24 h after T 4 infusion, even though activity was much lower than that after T 3 infusion. These data suggest that T 2 S is formed mainly in the fetal compartment and then transferred to the maternal side and finally excreted into maternal urine (4, 6) . The rate of T 2 S formed from T 3 is significantly higher than that from T 4 ( Table 4) . Distribution of radioactivity in maternal and fetal sera after the intravenous infusion of 125 I-T 4 in maternal ewes. As shown in Table 5 , after labeled T 4 infusion to maternal ewes (n ϭ 3), the ratios of fetal to maternal serum radioactivities (F/M) were 0.006 -0.014 in the first 4 h, increasing to 0.105 at 24 h. The radioactivities were not further characterized by HPLC.
DISCUSSION
The present study demonstrates a rapid clearance of labeled T 3 from fetal serum following its infusion; the T 1/2 is 0.7 h (Fig. 1) . The initial rapid decline in T 3 radioactivity may also involve distribution. However, the fact that large amounts of iodide and T 2 S accrue after 1 h suggests that metabolism plays an important role. Fetal T 3 undergoes rapid inner-ring monodeiodination to 3,3=-T 2 , which is an excellent substrate for all known mammalian iodothyronine sulfotransferases (10 -16) . The rapid sulfoconjugation of the hydroxyl group in the outer-ring of 3,3=-T 2 forms a hydrophilic sulfated T 2 (T 2 S) with enhanced permeability through placental membranes, facilitating transfer to maternal compartments. The T 2 S of fetal origin appears to be rapidly cleared from the maternal circulation via excretion in urine, as shown in Table 2 .
Fetal T 4 , on the other hand, disappears from the fetal circulation at a slower rate; a fast phase (T 1/2 2.4 h) in the first 3 h is followed by a slow phase (T 1/2 17.5 h). The major metabolites in fetal circulation after infusion of 125 I-T 4 were rT 3 and T 3 as well as their sulfates, T 4 S, rT 3 S, and 3,3=-T 2 S. Negligible amounts of T 3 S, 0.7-1.2%, were detected (Table  1) . Similarly to fetal T 3 infusion, the most abundant metabolite found in maternal urine following radioactive T 4 infusion is T 2 S ( Table 2 ). The T 4 infusion study confirms previous data in ovine fetuses (2, 4, 6) indicating that the production of active thyroid hormone (T 3 ) is less than production of inactive products (1.8 versus 3.1% dose/L, respectively in h 1 and 1.9 versus 8.9% dose/L, respectively in h 4, Table 1 ). It is also interesting that free iodide comprises 14.5-16.8% dose/L generated in the first 3 h and this far exceeds the identified metabolites (4.9 -6.5% dose/L in total). This suggests that the lower serum levels of radioactive metabolites are due to rapid distribution and/or production of deiodinated metabolites that are not identified by HPLC. The former is a more likely possibility inasmuch as, by h 4, the percentage dose of metabolites becomes equal to that of free iodine (10.6 versus.ϭ 10.8% dose/L, Table 1 ), indicating that little, if any, deiodinated metabolites were unaccounted for by HPLC.
It appears that a significant amount of T 3 formed in the fetal circulation is converted to T 2 S and transferred to the maternal compartment for deiodination/excretion. This process would contribute to the low circulating T 3 levels in the fetus. Because T 2 S appears to be quantitatively derived from circulating T 3 in the fetus, a significant increase or decrease in T 2 S in the maternal circulation would suggest hyper-or hypothyroidism in the fetus. We have shown that the amount of T 2 S excretion in maternal urine reflects fetal thyroid function in sheep (5) . Further, recent studies in rats have shown that 3,3=-T 2 stimulates mitochondrial respiration in various tissues (17) . It is possible that a tight regulation of T 2 concentration by sulfation and fetal-to-maternal transfer would have physiologic value. Enhancing fetal-to-maternal transfer may protect the fetus from excessive mitochondrial thermogenesis stimulated by high fetal concentrations of T 2 . Another T 2 , i.e. 3,5-T 2 , was also shown to stimulate mitochondrial thermogenesis (17) . 3,5-T 2 was not evaluated in the present study but it is likely that the active inner-ring (type 3) deiodinase in fetal mammals rapidly deiodinates 3,5-T 2 to T 1 (18) .
The present study also demonstrated fetal-to-maternal transfer of sulfated iodothyronine metabolites, particularly T 2 S, but to a lesser degree T 3 S, rT 3 S, and T 4 S. We also demonstrated unconjugated iodothyronines as well as an uncharacterized derivative in maternal urine ( Table 2 ). The site of sulfoconjugation of iodothyronines is likely fetal tissues since there is a much higher specific activity of the T 2 S in fetal sera relative to maternal urine ( Table 4 ). The lower specific activities of T 2 S in maternal urine than in fetal serum imply that T 2 S is formed in pools that do not equilibrate with fetal serum T 2 S. Whether these pools are in the fetus (possibly derived from the unlabeled iodothyronine in placental tissues) or are of maternal origin is not clear from the present data.
Fetal-to-maternal transfer would involve the placental circulation which comprises 40 -50% of fetal cardiac output (19) . The placental transfer of T 2 S and other T 3 metabolites to the maternal circulation appears to be an active process helping maintain serum T 3 in fetuses at very low levels. This is consistent with the previous findings of Sack and co-workers (20) , who showed that umbilical cord cutting triggers hypertriiodothyroninemia in the newborn lamb, and that the postnatal T 3 surge can be delayed until well after the TSH peak by delaying umbilical cord cutting. Santini et al. (21) also have shown that the placenta plays an important role in maintaining the low serum T 3 in fetuses late in gestation. The present study and the aforementioned studies of Sack et al. and Santini et al. point out the importance of the intact umbilico-placental unit and the continuing fetal-maternal exchange for maintaining 
